STUDY QUESTION: Can a pre-in vitro maturation (pre-IVM) medium containing signaling molecules rather than chemical/pharmaceutical agents, sustain meiotic arrest and improve developmental competence of in vitro matured oocytes in CF1 outbred mice?
Introduction
In vitro maturation (IVM) is not a routine technique used in human clinical assisted reproductive technology (ART) due to reduced embryo development and pregnancy outcomes following IVF (Gremeau et al., 2012; ASRM, 2013) . One factor contributing to poor results following IVM is the use of inadequate IVM conditions that do not support oocyte competence (Eppig et al., 2009; Gilchrist, 2011) . However, IVM could be a beneficial clinical alternative to conventional IVF. It reduces the adverse effects of exogenous hormones used to stimulate follicle growth and eliminates ovarian hyperstimulation syndrome (OHSS), and is time and cost effective compared to standard IVF procedures (Edwards, 2007; Rose et al., 2014) .
Because of its potential benefit to infertile patients, as well as agricultural and biomedical applications, much research has gone into the development of protocols and culture systems to improve IVM efficiency (reviewed in Smitz et al. (2011) and Walls et al. (2012) ). Although IVM typically promotes nuclear maturation, it fails to adequately support cytoplasmic maturation and thus subsequent fertilization, embryo development, implantation and pregnancy are compromised (Eppig et al., 2009; Li and Albertini, 2013; Coticchio et al., 2015) . Unfortunately, cytoplasmic maturation remains poorly understood. One approach to improve oocyte competence has been to utilize conditions that arrest or delay spontaneous meiotic resumption prior to IVM, to potentially synchronize nuclear and cytoplasmic maturation events and improve oocyte competence (Downs et al., 1986; Sirard and First, 1988; Lonergan et al., 1997; Luciano et al., 1999; Mermillod et al., 2000; Wu et al., 2002; Nogueira et al., 2006; Vanhoutte et al., 2007; Albuz et al., 2010; Richani et al., 2014; Zeng et al., 2014) .
In vivo, the oocyte is maintained in meiotic arrest by C-type natriuretic peptide (CNP) secreted from the mural granulosa cells. CNP binds to its receptor on the cumulus cells and stimulates production of cyclic guanosine monophosphate (cGMP). The cGMP is then transferred to the oocyte though gap junctions and functions to inhibit phosphodiesterase (PDE) 3A, resulting in the inhibition of cAMP degradation and the maintenance of meiotic arrest (Norris et al., 2009 (Norris et al., , 2010 Zhang et al., 2010; Robinson et al., 2012; Lee et al., 2013) . Oocyte nuclear maturation is initiated in vivo in response to the ovulatory surge of luteinizing hormone (LH), which induces closure of gap junctions and de-phosphorylation and inactivation of natriuretic peptide receptor (NPR) in somatic cells (Egbert et al., 2014) . In the oocyte, lack of cGMP from the cumulus cells results in activation of PDE3A and hydrolysis of cAMP, causing meiotic resumption (reviewed in Sun et al. (2009) , Conti et al. (2012) and Liu et al. (2013) ). On the contrary, during IVM the removal of the immature oocyte from its antral follicle leads to a rapid drop in cAMP concentration in both somatic cells and the oocyte, resulting in spontaneous meiotic resumption (Dekel et al., 1988; Yoshimura et al., 1992; Norris et al., 2009; Vaccari et al., 2009; Albuz et al., 2010) . Thus, in both in vivo and in vitro matured oocytes, a decrease in cAMP concentration triggers meiotic resumption (Schultz et al., 1983; Vivarelli et al., 1983 ). However, a major difference exists in that in vivo maturation is stimulated, whereas IVM occurs as a response to removal of the meiotic inhibitory signal.
Strategies employed to block meiotic resumption typically target oocyte cAMP levels. The broad spectrum PDE inhibitor IBMX (3-isobutyl-1-methylxanthine) has been used to prevent the drop in cAMP in the oocyte, an adenylate cyclase activator (forskolin, FSK) to stimulate the production of cAMP, or a cell permeable cAMP analog (8-br-cAMP or dbcAMP) to artificially maintain elevated cAMP concentration in the cumulus oocyte complex (COC) (Dekel et al., 1988; Downs et al., 1988; Funahashi et al., 1997; Luciano et al., 1999; Nogueira et al., 2003a Nogueira et al., , b, 2006 Thomas et al., 2004; Shu et al., 2008; Li et al., 2016) . Most of these products are general inhibitors and/or pharmacologic agents that target the entire COC, resulting in a non-physiological approach that for the most part has not resulted in improved oocyte quality. Nevertheless, a short period of meiotic arrest prior to IVM using IBMX and FSK, called 'SPOM' (simulated physiological oocyte maturation), improves developmental competence of mouse and bovine oocytes (Albuz et al., 2010) . However, attempts to repeat these results have been inconsistent (Guimaraes et al., 2015) , due in part to discrepancies in the SPOM protocol across laboratories (Gilchrist et al., 2015) . Recently, inhibition of meiotic resumption in the presence of physiologic ligand/receptor reagents (CNP, estradiol) instead of synthetic reagents like forskolin and PDE inhibitors has been shown to better enable normal functions of the rat COC in vitro (Campen et al., 2015) , maintaining gap junction activity and supporting key gene expression critical for oocyte maturation. Unprimed, juvenile immature oocytes have improved developmental competence when treated with pre-IVM using CNP (Romero et al., 2016) .
The objective of our experiments was to develop a physiological ligand/receptor pre-IVM medium targeting cumulus cells to improve oocyte competence following IVM in the mouse. COC are placed into a defined pre-IVM culture medium devoid of general pharmacological inhibitors and activators, instead taking a completely physiological approach targeting the cumulus cells (CNP, estradiol, BMP15 and a low concentration of FSH) to promote meiotic arrest. CNP stimulates the production of cGMP and estradiol helps to maintain CNP receptors on cumulus cells (Zhang et al., 2011) . BMP15 and low concentration of FSH help keep gap junctions open (Luciano et al., 2011; Franciosi et al., 2014; Sugimura et al., 2014) . We hypothesize that this pre-IVM medium works by prioritizing a ligand/receptor interaction with cumulus cells to keep the oocyte in meiotic arrest by maintaining gap junction communication between cumulus cells and the oocyte.
Materials and Methods
Unless specified otherwise, all chemicals were purchased from SigmaAldrich (St Louis, MO, USA). The gas concentrations used for pre-IVM, IVM, IVF and embryo culture (7.5% CO 2 and 6.5% O 2 ) are increased to compensate for the elevation of our laboratory (1830 m above sea level) and are equivalent to 6% CO 2 and 5% O 2 at sea level. Oocyte and embryo culture was conducted at 37°C.
Ethical approval
All mouse protocols were approved by the Fertility Labs of Colorado Ethics in Research Committee and followed animal care and use guidelines, as described by the Guide for the Care and Use of Laboratory Animals (Guide for the Care and Use of Laboratory Animals, 2011; National Research Council, 2011) .
Oocyte collection, meiotic arrest and maturation
Outbred (CF1) mice were obtained from Harlan Laboratories (Indianapolis, IN, USA) and maintained on a 14/10 h light/dark cycle with ad libitum access to food and water. For collection of immature oocytes, 5-12 week old mice were euthanized 46-48 h after i.p. injection of 5 IU pregnant mare's serum gonadotropin (Calbiochem, Billerica, MA, USA).
Ovaries were removed and COC recovered by follicular puncture. One ovary from each female was randomly placed into one of two treatments so that each female was equally represented in each treatment to eliminate individual female effects. Ovaries and COC in the pre-IVM treatment were recovered in 3-(N-morpholino)propanesulfonic acid (MOPS) buffered medium with meiotic inhibitors (10 μM cilostamide (a specific PDE3 inhibitor), 10 μM sildenafil (a specific PDE5 inhibitor), 100 nM estradiol, 30 nM CNP) and 5% fetal calf serum (FCS). Control ovaries and COC were recovered in MOPS buffered medium with 5% FCS. Only COC with several layers of unexpanded cumulus cells were selected and subsequently cultured (10 COC per 50 μL drop under oil; Ovoil; Vitrolife, Goteborg, Sweden) in a defined pre-IVM (PIM) or IVM (control) medium. Treated COC were cultured for 2 h or 24 h (depending on the experiment) in PIM medium, which is a modified version of the IVM medium that includes inhibitors of meiotic resumption (30 nM CNP, 100 nM estradiol, 1 * 10 −4 IU/ml rh-FSH (Gonal-f; Serono), 100 ng/ml BMP15 (R&D Systems)) and excludes EGF. The mitochondrial stimulator pyrroloquinoline quinone (PQQ) was added at a concentration of 10 μM in the last series of experiments. To determine gap junction functionality, after 20 h in PIM medium a subgroup of COC were transferred without washing to fresh PIM medium supplemented with 100 μM of carbenoxolone (CBX) (a gap junction inhibitor) and cultured for an additional 4 h. To determine nuclear status, oocytes were fixed and stained using aceto-orcein as previously described (Laforest et al., 2005) . Oocytes were classified into three groups: germinal vesicle (GV) stage oocytes, corresponding to oocytes that did not mature; germinal vesicle breakdown (GVBD)/metaphase I (MI) stage oocytes (GVBD/MI stage), corresponding to oocytes that did resume meiosis but did not complete nuclear maturation; and metaphase II (MII) stage oocytes, corresponding to oocytes that matured successfully.
COC from both control and pre-IVM treatment groups were matured in a defined non-commercial IVM medium for 18 h (1.5 mM glucose, 0.5 mM pyruvate, 4.0 mM lactate, 0.5 μg/ml insulin, 0.275 μg/ml transferrin, 0.25 ng/ml selenium, 10 ng/ml EGF, 1.5 mg/ml fetuin, 0.1 mM taurine and 2.5 mg/ml recombinant human albumin (AlbIX; Novozymes, Bagsvaerd, Denmark)), developed based on previously published data with minor modifications (Paczkowski et al., 2014) .
Mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was determined using the mitochondrial stain 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocynanine iodide (JC-1; Invitrogen, Carlsbad, CA, USA), as described previously (Silva, 2015; Wu et al., 2015) . Briefly, mature oocytes were collected after 18 h of IVM, denuded and stained with 2 μM JC-1 dye for 15 min at 37°C in the dark. Cells were then washed 3 times and imaged using a confocal microscope (Fluoview; Olympus, Center Valley, PA, USA) with excitation and emission wavelengths of 590 and 610 nm, respectively, for JC-1 aggregates (red) and 485 and 535 nm, respectively, for monomers (green). In order to avoid saturation of the fluorescent signal, the brightest control oocyte was used initially as a reference to determine the laser and sensitivity settings. Processing and analysis of images were performed using Olympus Fluoview FV10-ASW 4.1. Results are expressed as the average ratio of red to green fluorescence per oocyte in arbitrary units.
ATP concentration
Mature oocytes were collected after 18 h of IVM, denuded and the zona pellucida and first polar body removed using a 5 mg/ml pronase (Sigma) solution in MOPS with washing. Zona-free, polar body-free oocytes were collected individually in 10 μL phosphate-buffered saline (PBS) and frozen at -80°C until analysis. ATP concentrations were determined using the ATP Bioluminescent Somatic Cell Assay Kit (Sigma), as described previously (Silva, 2015) .
In vitro fertilization, embryo culture and blastocyst cell determination
After maturation, oocytes were fertilized using spermatozoa from B6D2F1 male mice (≥8 weeks old). Spermatozoa were expelled from the cauda epididymis and vas deferens of both testes into IVF medium (Herrick, 2015) . After a 1 h capacitation period, spermatozoa were diluted in IVF medium and added to drops containing COC (10 COC per 50 μl drop under oil) at a final concentration of 1 × 10 6 spermatozoa per ml (Herrick, 2015) . Gametes were co-incubated for 6 h. After IVF, presumptive zygotes were washed and placed 10 per 20 μl drop under oil into a sequential embryo culture media system prepared in our laboratory (Silva, 2015) . Cleavage was evaluated 24 h after IVF on Day 1 (D1) of culture and uncleaved oocytes were removed. After 48 h in step one culture medium (Day 2), embryos were washed and transferred to step two culture medium. Blastocyst development and stage were assessed after a total of 96 h (Day 4) and 116 h (Day 5) of culture. Quantification of inner cell mass (ICM) and trophectoderm (TE) cells was performed on hatching and fully hatched blastocysts on D5. Blastocysts were fixed in 4% paraformaldehyde (PFA). Antibodies against SRY (sex determining region Y)-box 2 (SOX2; AN579; Biogenex, Fremont, CA, USA) to detect ICM cells and CDX2 (Caudal Type Homeobox 2) (MU392A-UC; Biogenex) to detect trophectoderm cells were used, as described previously (Bakhtari and Ross, 2014) . Stained embryos were analyzed using Olympus BX52 microscope and MetaMorph Microscopy Automation and Image Analysis Software.
Embryo morphokinetics
Embryos were cultured individually following IVF in an EmbryoSlide ® in the EmbryoScope ® (Vitrolife, Göteborg, Sweden). The time of division to the two cell, four cell, eight cell, blastocyst and hatching blastocyst stages was annotated. All time points were normalized to pronuclear fading (t0) to account for differences in the timing of sperm penetration during IVF. A picture of each embryo was taken every 10 min during the entire time course of embryo development and the resulting images were annotated/ analyzed using EmbryoScope ® software.
Non-surgical embryo transfer (NSET)
Embryo transfers were performed to assess implantation and fetal development of embryos produced after pre-IVM/IVM. Expanded and minimally hatching blastocysts were selected after 89 h of culture and incubated in 20 μl drops of EmbryoGlue (Vitrolife ® ) under oil for one hour prior to transfer. Day 2.5 pseudopregnant Swiss Webster females were used as recipients. Embryos from a single treatment were transferred to a single recipient female. Approximately equal numbers of embryos were transferred per mouse per treatment within each replicate (12 to 16 embryos per recipient female, per replicate) using the NSET device (Paratechs, Lexington, KY). A total of nine recipients per treatment were used; a total of 125 embryos were transferred for control, 131 embryos for PIM 2 h and 124 embryos for PIM 24 h. Implantation and fetal development was determined on D15.5 of gestation. Resorption sites, fetal crown-rump length and fetal and placental weights were assessed.
Statistical analysis
Data were analyzed using NCSS software (Number Cruncher Statistical System, Kaysville UT, USA). For blastocyst development and cell number, embryo kinetics, embryo transfer results, ATP, and mitochondrial membrane potential, a one-way ANOVA was performed with treatment as a fixed factor. The percentage of pregnant females following embryo transfer was analyzed by Chi Square. In experiments with greater than two treatments, a Bonferroni multiple comparison test was used. Differences were determined to be significant when P < 0.05.
Results

Meiotic arrest and IVM
We first examined the kinetics of meiotic resumption during IVM in control oocytes and oocytes cultured for two or 24 h PIM prior to IVM. Control IVM oocytes all resumed meiosis after 2 h of culture (100% GVBD/MI), and all the oocytes were mature (MII) after 18 h of IVM (100% MII; Fig. 1A) . After a short 2 h pre-IVM period, 100% of oocytes remained at the GV stage (Fig. 1B) . After a 2 h pre-IVM period and 2 h of IVM, 23.7 ± 6.3% of the oocytes remained at the GV stage while 76.3 ± 6.3% had undergone GVBD. After a 24 h pre-IVM period, 100% of oocytes remained arrested at the GV stage (Fig. 1C) . After a 24 h pre-IVM period followed by 2 h of IVM, all oocytes had resumed meiosis (92.4% GVBD/MI and 7.6% MII). Moreover, gap junction communication is critical to the maintenance of meiotic arrest in this system, as oocytes subjected to the gap junction inhibitor CBX in the final 4 h of the 24 h arrest period in pre-IVM medium resumed meiosis (95.9 ± 2.1% GVBD/MI), whereas those not exposed to CBX during the final 4 h of the 24 h pre-IVM period remained arrested (98.2 ± 0.9% GV; Fig. 1D ). Cumulus expansion was not compromised by PIM.
A 24 h pre-IVM arrest period maintained the cumulus cells in a compact state, but following IVM these COC are normally expanded ( Fig. 2 and Supplementary data video S1).
Embryonic development, cell allocation and morphokinetics following meiotic arrest
A short 2 h period of meiotic arrest in PIM did not affect cleavage to the two cell stage, but improved blastocyst development after 96 h of culture per cleaved embryo compared to control (71.9 ± 7.4% versus 53.3 ± 6.2%, respectively; Fig. 3A ). There was no difference in blastocyst development at 96 h of culture following a 24 h meiotic arrest in PIM compared to control (69.7 ± 6.8% versus 76.1 ± 1.4%, respectively; Fig. 3B ).
To assess the quality of the embryos produced following meiotic arrest in PIM, cell allocation was determined in D5 hatching/hatched blastocysts (Fig. 4) . There was no difference in the number of trophectoderm (TE) or inner cell mass (ICM) cells in embryos produced following IVM/IVF/IVC after PIM treatment for either two or 24 h compared to control (Fig. 4B and C) . The proportion of Sox2 positive (ICM) cells was not different after meiotic arrest for 2 h in PIM, although the percentage of ICM cells was significantly increased in blastocysts developing after 24 h meiotic arrest in PIM compared to control (11.2 ± 0.7% versus 9.2 ± 0.5%, respectively; Fig. 4D and E) .
To further assess the quality of embryos produced following meiotic arrest in PIM, the kinetics of embryo development was assessed using time lapse imaging (Fig. 5 ). There were no differences in morphokinetics at any of the time points analyzed (time of division to two cells, four cells, eight cells, blastocoel cavity formation and blastocyst hatching) between embryos derived from control IVM eggs and those that were meiotically arrested for either 2 h or 24 h prior to IVM (Fig. 5) . 
Embryo transfer
Pregnancy rate per female was improved following transfer of embryos derived from eggs that had been meiotically arrested for 2 h, compared to control IVM derived embryos (Fig. 6A) . Implantation was also improved after transfer of embryos derived from oocytes arrested for either two or 24 h prior to IVM, IVF and IVC, compared to control IVM embryos (41.9 ± 9%, 37.2 ± 9.5% and 17.2 ± 8.3%, respectively; Fig. 6B ), although fetal development per embryo transferred did not differ between treatments. Crownrump length, and fetal and placentae weights were not different between treatments (Fig. 6C and D ).
Mitochondrial energy production
Mitochondrial membrane potential was higher in mature oocytes following meiotic arrest for 2 h and IVM compared to control IVM oocytes (red:green ratio, 0.87 ± 0.05 and 0.51 ± 0.04, respectively) (Fig. 7A) . On the contrary, mitochondrial activity was lower in mature oocytes following 24 h of arrest and IVM compared to control IVM oocytes (0.42 ± 0.05 and 0.72 ± 0.06, respectively) (Fig. 7B) . Addition of mitochondrial stimulator PQQ during PIM 24 h rescued mitochondrial activity to levels equal to control oocytes (0.66 ± 0.08 and 0.72 ± 0.06, respectively) (Fig. 7B) . The level of ATP in mature oocytes did not differ between treatments (Fig. 7C) .
Embryonic development and cell allocation following a 24 h pre-IVM period in the presence of PQQ
The presence of PQQ during the 24 h pre-IVM arrest period had no impact on embryonic development (Fig. 8) .
To assess the quality of the embryos produced following meiotic arrest in PIM 24 h and PIM 24 h in presence of PQQ, cell allocation was determined in D5 hatching/hatched blastocysts (Fig. 9) . There was no difference in the number of TE or ICM cells in embryos produced following IVM/IVF/IVC after PIM 24 h or 24 h with PQQ (Fig. 9A) . The proportion of Sox2 positive (ICM) cells was also not different between PIM24 and PIM24 + PQQ treatments (9.7 ± 0.4% versus 10.5 ± 0.5%, respectively; Fig. 9B ).
Discussion
Removing the COC from its follicular environment results in a premature decline in cAMP concentrations and spontaneous meiotic resumption (Pincus and Enzmann, 1935; Vivarelli et al., 1983; Tsafriri et al., 1996) , which is detrimental to oocyte quality. Subsequently, embryo development and establishment of pregnancy are reduced compared to embryos derived from in vivo matured oocytes (Eppig et al., 2009 ). Here, we described the impact of a ligand/receptorbased pre-maturation medium targeting cumulus cells and cGMP signaling on the developmental competence of mouse oocytes in vitro. Asterisk indicates statistically significant differences between treatments within an endpoint, P < 0.05.
We demonstrate that this pre-IVM medium arrests meiotic resumption for up to 24 h and keeps the gap junctions open, allowing passage of molecules between the cumulus cells and the oocyte. Use of a pre-IVM medium for 2 h after collection results in better quality oocytes than those matured via standard IVM. A 24 h arrest period does not improve, but neither is it detrimental, to subsequent embryo development, and may represent a window of opportunity to improve oocyte quality in vitro. Our initial experiments towards this goal demonstrate that the addition of pyrroloquinoline quinone (PQQ), a mitochondrial stimulator, during the 24 h arrest period restores mitochondria activity to control levels in mature oocytes, but does not improve embryo development in vitro nor embryo quality. Our results offer insights for the development of culture systems that can improve oocyte developmental competence in vitro. Because IVM is a promising technique that could considerably reduce the adverse effects and cost of human IVF, improvement in IVM protocols and media is of particular interest (Smitz et al., 2011; Wrenzycki and Stinshoff, 2013) . Modulation of cAMP concentration within the mammalian COC during maturation modestly improves oocyte developmental competence in several species, including human (Funahashi et al., 1997; Luciano et al., 1999 Luciano et al., , 2004 Nogueira et al., 2003a Nogueira et al., ,b, 2006 Thomas et al., 2004; Shu et al., 2008; Vanhoutte et al., 2009a,b; Albuz et al., 2010; Zeng et al., 2013 Zeng et al., , 2014 Li et al., 2016) . Modulation of cAMP before IVM, in a pre-IVM period of meiotic arrest also improves oocyte developmental competence (Albuz et al., 2010; Richani et al., 2014; Zeng et al., 2014; Li et al., 2016) , although the mechanisms involved are unclear. To date, the use of pre-IVM culture systems to improve developmental competence have yielded inconsistent results, and this technique is not yet used routinely (Gilchrist et al., 2015; Guimaraes et al., 2015) . In addition to the cAMP pathway, the CNP/cGMP pathway has been described as a major player in the Figure 4 Cell number and allocation in D5 hatched/hatching blastocysts following meiotic arrest. Embryos (A) were stained for Sox2 (ICM cells; green) and CDX2 (TE cells; red). Total cell number (B, PIM 2 h and C, PIM 24 h) and proportion of ICM cells (ICM:total cells) (D, PIM 2 h and E, PIM 24 h) were compared to control embryos. Data are expressed as mean ± SEM (n = 57 for control and 41 for PIM 2 h over four replicates; n = 62 for control and 55 for PIM 24 h over three replicates). Asterisk indicates statistically significant differences between treatments, P < 0.05. ICM, inner cell mass; TE, trophectoderm. regulation of meiosis in vivo and in vitro (Zhang et al., 2010; Kawamura et al., 2011; Kiyosu et al., 2012; Robinson et al., 2012; Franciosi et al., 2014; Santiquet et al., 2014) . Addition of physiologically-relevant granulosa cell-derived reagents like CNP and estradiol, rather than supplementation with pharmaceutical chemicals such as forskolin and PDE inhibitors, better enables normal physiological function of the COC during meiotic arrest in vitro (Campen et al., 2015) . We have used a similar approach in these experiments, demonstrating beneficial effects not only on oocyte nuclear maturation, but also on mitochondrial activity, blastocyst development and establishment of pregnancy.
Using a physiologic ligand/receptor-based approach, we demonstrate that gap junctions remain open, keeping the oocyte arrested for up to 24 h in vitro. Although spontaneous meiotic resumption can be delayed using pharmacological compounds, the transfer of molecules from the cumulus cells to the oocyte via gap junctions is compromised compared to a more physiological arrest in the presence of CNP and estradiol (Campen et al., 2015) . Estradiol maintains CNP receptors (NPR-2) on cumulus cells in mice (Zhang et al., 2011) , and increases NPR2 mRNA in bovine cumulus cells during IVM (Soares et al., 2017) . In addition, cumulus expansion is important to IVM as it is understood to be directly linked to fertilization and developmental success (Chen et al., 1993; Gutnisky et al., 2007) . In our arrest medium, cumulus expansion is prevented even after 24 h of arrest, and subsequent expansion following IVM is stimulated and was comparable to control, indicating that the arrested oocytes follow a physiological maturation process. To manage inter-mouse variability that can be higher in CF1 outbred females (Khan et al., 2013; Herrick et al., 2016) , our experimental design allocated one ovary from each female to each experimental treatment during collection. Thus, this design minimizes variability between treatments due to female, but only permits comparison of the control to one experimental treatment in a single experiment. Outbred CF1 mice are a more sensitive strain compared to others mouse strains, particularly for IVM/IVF (Khan et al., 2013; Herrick et al., 2016) .
It is interesting to note that despite the fact that oocytes successfully complete nuclear maturation after both a 2 and 24 h arrest period, oocytes arrested for just 2 h progress through meiosis more slowly than those arrested for 24 h. This delay in meiotic progression could potentially reflect the positive effect of a 2 h arrest on oocyte competence, and the lack of a positive effect after a 24 h arrest period. Blastocyst total cell number was not different from control after arrest for either a short or long period, suggesting equivalent embryo quality. Morphokinetics are also indicative of embryo quality (reviewed in Kaser and Racowsky (2014) and Basile et al. (2015) ), but we found no effects of pre-IVM on the developmental kinetics of mouse embryos. Transfer of embryos produced following a 2 h meiotic arrest prior to IVM resulted in increased pregnancy rate, and implantation rate was improved after transfer of embryos produced with both the short and long meiotic arrest period. This demonstrates that embryos derived from oocytes held in meiotic arrest in a pre-IVM system are more competent to establish pregnancy compared to their nonarrested standard IVM counterparts. Although blastocysts produced after pre-IVM were more competent to implant, we observed higher embryonic loss post-implantation, resulting in equal numbers of developing fetuses per transferred embryo derived from pre-IVM and IVM blastocysts. To our knowledge, this is the first report of fetal development following IVM, IVF, IVC and transfer of outbred CF1 mouse embryos. These results suggest that although we have improved embryo quality with a 2 h pre-IVM period, additional improvements remain to be made in order to overcome the compromised quality of IVM embryos in this outbred strain.
Embryo development is correlated with mitochondria activity in oocytes (Wilding et al., 2001; Van Blerkom, 2011) . Previous studies have shown that mitochondrial membrane potential and ATP production are increased in the oocyte following a period of meiotic arrest (Zeng et al., 2013) . Thus, our results confirm the benefit of a short ligand/receptor-based pre-IVM meiotic arrest period on oocyte competence. However, we did not observe a corresponding increase in ATP concentration. In some species, but not all, lower ATP concentrations in oocytes are associated with poor developmental competence (Quinn and Wales, 1973; Van Blerkom et al., 1995; Brad et al., 2003; Herrick et al., 2003) . Many MII oocytes displayed a large polar body with highly polarized, active mitochondria (data not shown). As such, the polar body could significantly impact ATP concentration. Unlike previously published studies, we removed the polar body prior to ATP analysis to examine only ATP concentrations in the oocyte that could subsequently impact results. Alternatively, ADP:ATP ratios may be more informative regarding future development than ATP levels alone, but we did not examine this parameter.
We view the 24 h period of meiotic arrest prior to IVM, with the gap junctions remaining open and functional, as a potential window of opportunity to manipulate and improve oocyte competence. Because mitochondria health and activity have been shown to be important for oocyte competence, we tested this idea by adding a well-known stimulator of mitochondria activity and biogenesis, PQQ (pyrroloquinoline quinone), which increases citrate synthase and cytochrome c oxidase activity, Mitotracker staining, mitochondrial DNA content, and cellular oxygen respiration in many cell types (Stites et al., 2006; Chowanadisai et al., 2010) . Addition of PQQ during the 24 h arrest period improved mitochondria activity of arrested oocytes to control levels. However, subsequent embryo development was not similarly improved. Nonetheless, the 24 h period of meiotic arrest remains a tantalizing target for manipulation of oocyte physiology to improve developmental competence. This may have important applications in human clinical ART, where a high proportion of patients are women of advanced maternal age and/or diminished ovarian reserve who suffer from poor oocyte quality.
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